Invesco Ltd. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$144.95 - $152.29 $6.68 Million - $7.02 Million
-46,097 Reduced 61.05%
29,416 $4.45 Million
Q2 2022

Aug 15, 2022
SELL
$83.14 - $145.99 $6.02 Million - $10.6 Million
-72,419 Reduced 48.95%
75,513 $11 Million
Q1 2022

May 16, 2022
SELL
$110.08 - $142.92 $8.52 Million - $11.1 Million
-77,433 Reduced 34.36%
147,932 $17.5 Million
Q4 2021

Feb 14, 2022
BUY
$99.73 - $148.48 $7.92 Million - $11.8 Million
79,404 Added 54.4%
225,365 $31.1 Million
Q3 2021

Nov 15, 2021
BUY
$98.85 - $138.91 $6.54 Million - $9.19 Million
66,154 Added 82.89%
145,961 $20.3 Million
Q2 2021

Aug 17, 2021
BUY
$65.78 - $105.02 $4.4 Million - $7.02 Million
66,845 Added 515.7%
79,807 $7.75 Million
Q1 2021

May 17, 2021
BUY
$64.07 - $91.75 $166,838 - $238,917
2,604 Added 25.14%
12,962 $886,000
Q4 2020

Feb 16, 2021
BUY
$65.07 - $98.24 $457,442 - $690,627
7,030 Added 211.24%
10,358 $888,000
Q3 2020

Nov 16, 2020
SELL
$59.04 - $77.95 $726,310 - $958,940
-12,302 Reduced 78.71%
3,328 $217,000
Q2 2020

Aug 14, 2020
BUY
$29.01 - $74.23 $453,426 - $1.16 Million
15,630 New
15,630 $1.14 Million
Q1 2020

May 15, 2020
SELL
$27.51 - $57.29 $6.95 Million - $14.5 Million
-252,670 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$40.86 - $57.65 $346,043 - $488,237
-8,469 Reduced 3.24%
252,670 $13.8 Million
Q3 2019

Nov 14, 2019
BUY
$37.38 - $49.47 $1.93 Million - $2.56 Million
51,706 Added 24.69%
261,139 $10.9 Million
Q2 2019

Aug 14, 2019
BUY
$39.79 - $67.01 $808,214 - $1.36 Million
20,312 Added 10.74%
209,433 $9.17 Million
Q1 2019

May 15, 2019
SELL
$34.52 - $53.29 $687,638 - $1.06 Million
-19,920 Reduced 9.53%
189,121 $9.73 Million
Q4 2018

Feb 14, 2019
BUY
$29.75 - $42.9 $6.22 Million - $8.97 Million
209,041 New
209,041 $7.73 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email